COMPREHENSIVE DERMATOLOGIC DRUG THERAPY WITH ACCESS CODE 4ED (HB 2021)

WOLVERTON S.E.

ISBN 10: 0323612113 / ISBN 13: 9780323612111

Published by ELSEVIER RS EXCL MED(40), 2021

About this Item

Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.

Seller Inventory # TCBS 9780323612111

Bibliographic Details

• Title: COMPREHENSIVE DERMATOLOGIC DRUG THERAPY WITH ACCESS CODE 4ED (HB 2021)
• Publisher: ELSEVIER RS EXCL MED(40)
• Publication Date: 2021
• Language: English
• ISBN 10: 0323612113
• ISBN 13: 9780323612111
• Binding: Hardcover
• Edition: 4th Edition, International Edition
• Condition: New Books

About this title

Synopsis

**Selected for 2026 Doody's Core Titles in Dermatology**

Designed with practical usability in mind, Comprehensive Dermatologic Drug Therapy, 4th Edition, helps you safely and effectively treat the skin disorders you’re likely to see in your practice. Dr. Stephen E. Wolverton and new associate editor Dr. Jashin J. Wu lead a team of global experts to bring you concise, complete guidance on today's full spectrum of topical, intralesional, and systemic drugs. You’ll prescribe with confidence thanks to expert coverage of which drugs to use, when to use them, and adverse effects to monitor.

• Includes new drug interaction tables, drug risk profiles, and FDA guidelines, as well as two new appendices that summarize chapter questions and summarize highest-risk drug interactions
• Covers the best uses for new biologic therapeutics
• Contains new chapters covering medical decision-making principles, PDE-4 and JAK inhibitors, interleukin 17 inhibitors, interleukin 23 inhibitors, additional biologic therapeutics, and hedgehog pathway inhibitors
• Contains quick-access summaries of indications/contraindications, dosage guidelines, drug interactions, drug monitoring guidelines, adverse effects, and treatment protocols
• Features a highly detailed, disease-specific index, as well as purchase information for major drugs
• Helps you assess your knowledge and prepare for certification or recertification with about 800 review questions and answers throughout the book
• Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices